menu
    • menu

    Company profile for Bellerophon Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases. We are currently developing three product candidates under our INOpulse platform, a proprietary pulsatile nitric oxide drug delivery system. The first is for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD)...
    We are a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases. We are currently developing three product candidates under our INOpulse platform, a proprietary pulsatile nitric oxide drug delivery system. The first is for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD). The second product candidate is for the treatment of pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD) and the third is for the treatment of pulmon

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bellerophon TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Bellerophon Therapeutics 184 Liberty Corner Road, Suite 302 Warren, NJ 07059
    Telephone
    Telephone
    908-574-4770
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bellerophon.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/bellerophon-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bellerophon lets almost all employees go, looks for deals in wake of PhIII flop
    Bellerophon lets almost all employees go, looks for deals in wake of PhIII flop

    30 Jun 2023

    // Amber Tong ENDPTS

    https://endpts.com/bellerophon-therapeutics-lets-almost-all-employees-go-looks-for-deals-in-wake-of-phiii-flop/

    Amber Tong ENDPTS
    30 Jun 2023
    Share Share
    Bellerophon’s study of fILD therapy fails to meet primary endpoint
    Bellerophon’s study of fILD therapy fails to meet primary endpoint

    06 Jun 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/bellerophon-therapeutics-fild-trial/

    CLINICAL TRIALS ARENA
    06 Jun 2023
    Share Share
    Bellerophon's stock tanks as inhaled drug-device fails to redeem itself
    Bellerophon's stock tanks as inhaled drug-device fails to redeem itself

    05 Jun 2023

    // Amber Tong ENDPTS

    https://endpts.com/bellerophon-therapeutics-drug-device-fails-another-phiii-in-lung-disease-stock-implodes/

    Amber Tong ENDPTS
    05 Jun 2023
    Share Share
    Bellerophon Announces Top-Line Data from Ph 3 REBUILD Clinical Trial of INOpulse
    Bellerophon Announces Top-Line Data from Ph 3 REBUILD Clinical Trial of INOpulse

    05 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/05/2681822/0/en/Bellerophon-Announces-Top-Line-Data-from-Phase-3-REBUILD-Clinical-Trial-of-INOpulse-for-Treatment-of-Fibrotic-Interstitial-Lung-Disease.html

    GLOBENEWSWIRE
    05 Jun 2023
    Share Share
    Bellerophon Provides Clinical Program Update and Reports 1Q 2023 FYR Results
    Bellerophon Provides Clinical Program Update and Reports 1Q 2023 FYR Results

    15 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/15/2669391/0/en/Bellerophon-Provides-Clinical-Program-Update-and-Reports-First-Quarter-2023-Financial-Results.html

    GLOBENEWSWIRE
    15 May 2023
    Share Share
    Bellerophon Announces Last Patient Has Completed Blinded Treatment in PIII REBUILD Study
    Bellerophon Announces Last Patient Has Completed Blinded Treatment in PIII REBUILD Study

    11 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/11/2666738/0/en/Bellerophon-Therapeutics-Announces-Last-Patient-Has-Completed-Blinded-Treatment-in-Phase-3-REBUILD-Study-for-INOpulse-in-Fibrotic-Interstitial-Lung-Disease.html

    GLOBENEWSWIRE
    11 May 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search